In this page, we are going to cover the Aurora Cannabis stock, which is one of the stocks you can analyze and is currently gaining popularity. In particular, you will be able to discover in this article the information that will be useful for your analyzes of this value. For example, we will present to you in detail this company and its activities and sources of profits. We will also be interested in its main competitors in the market and in the same sector or in its most recent partnerships. Of course, we will also reveal the data and publications that you must follow in order to carry out good fundamental analyzes of this title.
We will first take into account the evolution of international regulations regarding medical cannabis. With the opening of certain markets such as European markets to this type of treatment, there is a good chance that companies already in place like Aurora Cannabis will develop their activities and their profitability.
The innovations and new hemp products that the company can develop will also be good indicators of its possibilities for future growth. Indeed, it is advisable to closely follow the research of this group as well as its possible research partnerships allowing it to stand out from its competitors.
Besides, competition is also an element that you must follow closely as part of your fundamental analysis of this action. With the cannabis sector having low barriers to entry, Aurora Cannabis may find itself confronting more and more competitors.
It will of course be necessary to keep an eye on all official communications on the part of this group, in particular with regard to its strategic development plans or even its forecasts for future financial results.
Of course, the publication of annual and quarterly financial statements of this company will help you to see more clearly with regard to its evolution over time and its possible growth in the years to come.
Finally, you can also base this analysis on dividend publications by monitoring changes in investor compensation over time
Let's now discover the company that is Aurora Cannabis by trying to learn more about its activities and its main sources of income. This knowledge is essential if you want to make a good analysis of this value taking into account the different sectors and segments on which it bases its profit strategy.
The Aurora Cannabis group is a Canadian company that specializes in medical cannabis. It is currently one of the leaders in this sector of the world.
To carry out its activities, Aurora Cannabis has several subsidiaries and manages two different operating sectors as well as a head office. The group also has several horizontally integrated companies. Through its activities in the medical cannabis segment, Aurora Cannabis produces and distributes cannabis for therapeutic purposes in Canada and also supplies cannabis wholesale in the European Union. But that's not all. This company also markets indoor growing systems and hemp-based food products. Each year, more than 625000 kilos of cannabis are produced by this group, which employs 2779 people worldwide.
It is interesting to know how the turnover of this company is distributed between the different markets from a geographical point of view. Aurora Cannabis thus generates most of its turnover in Canada. The European Union only represents 4.8% of its turnover and the rest of the world only 1.4%.
After having read the essential information concerning Aurora Cannabis, we suggest that you learn a little more about its sector of activity by taking a closer look at its direct competitors. Aurora Cannabis is indeed one of the giants of this industry in the world, but still has some important opponents here:
This multi-brand Canadian company also operates through various subsidiaries and offers the production and sale of legal cannabis on the medical market in Canada. Unlike Aurora Cannabis, it also offers recreational cannabis in this same market.
This is number 3 in this sector. This company is engaged in the pharmaceutical sector and supplies cannabis-based products to pharmaceutical distributors. Its activities are particularly focused on medical research on cannabis, the cultivation, processing and distribution of cannabis products around the world. It also produces and markets other hemp-based products through a specific subsidiary, including hemp heart, hemp oil, hemp granola, hemp protein powder and hemp milk. Tilray also offers cannabis products to patients in certain countries of the world and across five continents through subsidiaries located in Australia, Canada and Germany. Its medical cannabis is produced only in Canada and Europe.
Finally, Aurira Cannabis' last serious competitor is Trulieve Cannabis, which is also a vertically integrated Canadian company that sells licensed medical cannabis seeds. This company cultivates and manufactures its products on the internet and distributes them to dispensary stores under its own brand but also directly to patients through a home delivery service.
Of course, Aurora Cannabis would not have become the company it is today without certain allies. It is therefore very important to pay attention to the various partnerships that this group can set up with other companies. Here are some concrete examples of such partnerships.
The first partnership we will tell you about was set up in 2019 with the American mixed martial arts organization UFC in order to test CBD products on athletes to relieve their pain. A first phase of research was thus carried out in the laboratory to understand the possible uses of this ingredient for high performance athletes and the development of suitable products. A second phase should consist of testing these products on volunteer athletes in order to validate their safety and effectiveness.
Another partnership was set up the same year with McGill University as part of an international medical research project carried out jointly by the two entities, the aim of which is to study the therapeutic effects and impact on human health of cannabidiol oil to treat chronic pain and anxiety or depression.
Finally, according to certain sources, Aurora Cannabis and Coca-Cola are currently discussing a possible rapprochement in the field of therapeutic cannabis with the possibility for the American group to market in the future beverages containing cannabis infusions.
Of course, the products developed by Aurora Cannabis are tested in the laboratory and you can consult the results of these tests directly on its official website or on its mobile application. Since 2017, the group has enabled the general public to access simplified certificates of analysis for each of its products available for sale and thanks to a system developed with Anandia Labs.
As the Aurora Cannabis share is listed both on the Toronto market and on the NYSE, you have the possibility of investing in its price at the usual opening hours of these two financial centers. For the TSX, these opening hours are between 9 a.m. and 30 p.m. (local time) and for the NYSE, from 16 a.m. to 9 p.m. also with trading hours before and after the market opens, i.e. from 30 a.m. to 16 a.m. and from 4 p.m. At 9 o 'clock.
The Aurora Cannabis group notably announced in 2018 the acquisition of the company CanniMed Therapeutics for an amount of CAD 1.1 billion and in the field of veterinary health. The same year, another major takeover was made, that of the company RedReleaf and this time for an amount of 3.2 billion Canadian dollars. This new acquisition has enabled the group to create a new group with 9 production units in Canada and 2 in Denmark.
eToro is a multi-asset platform offering both equity as well as asset trading in the form of CFDs.
Please note that CFDs are complex instruments and present a high risk of rapid loss of funds due to their leverage effect. 67% of retail traders' accounts lose funds when trading CFDs with this supplier. You should ask yourself if you understand how CFDs work and if you can afford to take the significant risk of losing your money.
The content in question is provided for information purposes only and should not be considered as investment advice. Past performance is no guarantee of future results. The trading history is less than 5 years old and may not be sufficient to serve as a basis for an investment decision.
Crypto-actives are volatile instruments that can fluctuate considerably over a very short period of time and are therefore not suitable for all investors. Other than through CFDs, crypto-active trading is not regulated by any EU regulatory framework and is therefore not supervised. This is an advert for trading CFDs on eToro
